Rumi Scientific

Rumi Scientific is a research-driven company headquartered in New York, New York. This small company, with 10 employees, is dedicated to discovering new drugs and treatments for human genetic diseases affecting the central nervous system. The company has developed a groundbreaking human organoid-based platform for drug discovery. This platform allows for agnostic drug screening and can be readily translated into high-throughput screening. Rumi Scientific’s platform uses embryonic stem cells to model human development in a laboratory setting. They combine this with gene editing to create genetically accurate models of human diseases, ultimately forming defined pathological embryonic tissues ideal for drug screening using artificial intelligence. Rumi Scientific is currently focused on developing treatments for Huntington’s Disease, but their research also extends to neurodevelopmental disorders. The company believes that their expertise in synthetic human embryology, both in healthy and diseased contexts, will lead to new treatments for a wide range of currently incurable genetic disorders. For more information about Rumi Scientific and their innovative research, please visit their website at rumiscientific.com.